The Liposome pipeline update
LIPO presented a comprehensive update on the status of its clinical trials.
The company has begun or will begin U.S. trials of ABLC amphotericin B lipid complex in four indications. A Phase II/III trial in the prevention
Gathering data...
LIPO presented a comprehensive update on the status of its clinical trials.
The company has begun or will begin U.S. trials of ABLC amphotericin B lipid complex in four indications. A Phase II/III trial in the prevention